NextCure Common Stock Shares Outstanding from 2010 to 2024

NXTC Stock  USD 1.54  0.04  2.53%   
NextCure's Common Stock Shares Outstanding is increasing over the years with slightly volatile fluctuation. Common Stock Shares Outstanding is expected to dwindle to about 23 M. Common Stock Shares Outstanding is the total number of shares of a company's common stock that are currently owned by all its shareholders. View All Fundamentals
 
Common Stock Shares Outstanding  
First Reported
2018-03-31
Previous Quarter
27.9 M
Current Value
27.9 M
Quarterly Volatility
6.9 M
 
Covid
Check NextCure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NextCure main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Depreciation And Amortization of 3.7 M or Interest Expense of 6.4 M, as well as many exotic indicators such as Price To Sales Ratio of 14.65, Dividend Yield of 0.0 or PTB Ratio of 0.29. NextCure financial statements analysis is a perfect complement when working with NextCure Valuation or Volatility modules.
  
This module can also supplement NextCure's financial leverage analysis and stock options assessment as well as various NextCure Technical models . Check out the analysis of NextCure Correlation against competitors.
For information on how to trade NextCure Stock refer to our How to Trade NextCure Stock guide.

Latest NextCure's Common Stock Shares Outstanding Growth Pattern

Below is the plot of the Common Stock Shares Outstanding of NextCure over the last few years. It is the total number of shares of a company's common stock that are currently owned by all its shareholders. NextCure's Common Stock Shares Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NextCure's overall financial position and show how it may be relating to other accounts over time.
Common Stock Shares Outstanding10 Years Trend
Slightly volatile
   Common Stock Shares Outstanding   
       Timeline  

NextCure Common Stock Shares Outstanding Regression Statistics

Arithmetic Mean15,986,221
Geometric Mean14,325,730
Coefficient Of Variation50.58
Mean Deviation7,175,935
Median10,038,582
Standard Deviation8,085,232
Sample Variance65.4T
Range17.8M
R-Value0.83
Mean Square Error21.9T
R-Squared0.69
Significance0.0001
Slope1,501,078
Total Sum of Squares915.2T

NextCure Common Stock Shares Outstanding History

202423 M
202327.8 M
202227.7 M
202127.6 M
202027.5 M
201915.7 M

About NextCure Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include NextCure income statement, its balance sheet, and the statement of cash flows. NextCure investors use historical funamental indicators, such as NextCure's Common Stock Shares Outstanding, to determine how well the company is positioned to perform in the future. Although NextCure investors may use each financial statement separately, they are all related. The changes in NextCure's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on NextCure's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on NextCure Financial Statements. Understanding these patterns can help to make the right decision on long term investment in NextCure. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Common Stock Shares Outstanding27.8 M23 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether NextCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NextCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nextcure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nextcure Stock:
Check out the analysis of NextCure Correlation against competitors.
For information on how to trade NextCure Stock refer to our How to Trade NextCure Stock guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for NextCure Stock analysis

When running NextCure's price analysis, check to measure NextCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextCure is operating at the current time. Most of NextCure's value examination focuses on studying past and present price action to predict the probability of NextCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextCure's price. Additionally, you may evaluate how the addition of NextCure to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is NextCure's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NextCure. If investors know NextCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NextCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.28)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.29)
Return On Equity
(0.50)
The market value of NextCure is measured differently than its book value, which is the value of NextCure that is recorded on the company's balance sheet. Investors also form their own opinion of NextCure's value that differs from its market value or its book value, called intrinsic value, which is NextCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NextCure's market value can be influenced by many factors that don't directly affect NextCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NextCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if NextCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NextCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.